1887
Research Open Access
Like 0

Abstract

BACKGROUND

is a fungal pathogen of major concern, that frequently exhibits multidrug resistance and causes healthcare-related outbreaks worldwide. Italy experienced a large nosocomial outbreak in early 2020, with subsequent sporadic cases or small clusters in different regions.

AIM

To provide an overview of the population structure, genomic diversity, and spread in Italy.

METHODS

Genome sequences from Italian isolates (n = 68) were obtained either from public databases, or by whole-genome sequencing of available isolates (n = 17) from previously uncharacterised and/or recently emerged (2025) cases. The sequence dataset was complemented with whole genome sequences of international isolates (n = 139) to conduct a global phylogenetic analysis based on core-genome single nucleotide polymorphisms. Genetic mutations associated with antifungal resistance were investigated.

RESULTS

All Italian isolates belonged to clade I (South Asian) but were interspersed among different subclades. Subclade Ic isolates were of a single lineage, characterised by the P238H mutation. This lineage spread over four regions. Subclade Ib members were more diverse, and associated with local or imported single cases, as well as nosocomial clusters following sporadic, independent introductions from countries in southern Europe. A putative new subclade (Id) was identified, involving isolates from Italy and an eastern European country. Subclades Ib-c-d exhibited lineage-specific genetic signatures in antifungal-resistance-associated loci ().

CONCLUSIONS

In Italy, strains form a complex population, resulting from emergence or evolution of clade I sub-lineages following, in some instances, sporadic introductions from other European countries. Strengthened screening protocols remain essential for inter-facility transfers and for patients with prior healthcare exposure abroad.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.18.2500730
2026-05-07
2026-06-10
/content/10.2807/1560-7917.ES.2026.31.18.2500730
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/18/eurosurv-31-18-4.html?itemId=/content/10.2807/1560-7917.ES.2026.31.18.2500730&mimeType=html&fmt=ahah

References

  1. Salmanton-García J, Nóbrega de Almeida J Jr, Colombo AL. Candidozyma auris (formerly Candida auris): resistant, long lasting, and everywhere. Clin Microbiol Infect. 2026;32(3):374-81.  https://doi.org/10.1016/j.cmi.2025.12.022  PMID: 41485706 
  2. Rhodes J, Abdolrasouli A, Farrer RA, Cuomo CA, Aanensen DM, Armstrong-James D, et al. Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. Emerg Microbes Infect. 2018;7(1):1–12.  https://doi.org/10.1038/s41426-018-0045-x  PMID: 29593275 
  3. O’Brien B, Liang J, Chaturvedi S, Jacobs JL, Chaturvedi V. Pan-resistant Candida auris: New York subcluster susceptible to antifungal combinations. Lancet Microbe. 2020;1(5):e193-4.  https://doi.org/10.1016/S2666-5247(20)30090-2  PMID: 35544199 
  4. Sharma D, Paul RA, Rudramurthy SM, Kashyap N, Bhattacharya S, Soman R, et al. Impact of FKS1 Genotype on Echinocandin In Vitro Susceptibility in Candida auris and In Vivo Response in a Murine Model of Infection. Antimicrob Agents Chemother. 2022;66(1):e0165221.  https://doi.org/10.1128/AAC.01652-21  PMID: 34780273 
  5. Mulet Bayona JV, Tormo Palop N, Salvador García C, Guna Serrano MDR, Gimeno Cardona C. Candida auris from colonisation to candidemia: A four-year study. Mycoses. 2023;66(10):882-90.  https://doi.org/10.1111/myc.13626  PMID: 37401661 
  6. Meletiadis J, Siopi M, Spruijtenburg B, Georgiou P-C, Kostoula M, Vourli S, et al. Candida auris fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023. Euro Surveill. 2024;29(45):2400128.  https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400128  PMID: 39512169 
  7. Codda G, Willison E, Magnasco L, Morici P, Giacobbe DR, Mencacci A, et al. In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022. Euro Surveill. 2023;28(14):2300161.  https://doi.org/10.2807/1560-7917.ES.2023.28.14.2300161  PMID: 37022211 
  8. Bhargava A, Klamer K, Sharma M, Ortiz D, Saravolatz L. Candida auris: A Continuing Threat. Microorganisms. 2025;13(3):652.  https://doi.org/10.3390/microorganisms13030652  PMID: 40142543 
  9. European Centre for Disease Prevention and Control (ECDC). Survey on the epidemiological situation, laboratory capacity and preparedness for Candidozyma (Candida) auris, 2024. Stockholm: ECDC; 2025. Available from: https://www.ecdc.europa.eu/en/publications-data/survey-epidemiological-situation-laboratory-capacity-and-preparedness-candidozyma
  10. Siopi M, Georgiou P-C, Paranos P, Beredaki M-I, Tarpatzi A, Kalogeropoulou E, et al. Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023. Euro Surveill. 2024;29(29):2300661.  https://doi.org/10.2807/1560-7917.ES.2024.29.29.2300661  PMID: 39027938 
  11. Mulet Bayona JV, Tormo Palop N, Salvador García C, Fuster Escrivá B, Chanzá Aviñó M, Ortega García P, et al. Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital. J Fungi (Basel). 2021;7(6):440.  https://doi.org/10.3390/jof7060440  PMID: 34072876 
  12. Cancino-Muñoz I, Mulet-Bayona JV, Salvador-García C, Tormo-Palop N, Guna R, Gimeno-Cardona C, et al. Short-term evolution and dispersal patterns of fluconazole-resistance in Candida auris clade III. MBio. 2025;16(2):e0316424.  https://doi.org/10.1128/mbio.03164-24  PMID: 39727422 
  13. Spruijtenburg B, Meis JF, van Rhijn N, Čurdová M, Kašperová E, Vašek P, et al. The rise of Candidozyma auris in Czechia: three clades, prosthetic joint infection and fluconazole resistance development, 2022 to 2024. Euro Surveill. 2025;30(45):2500285.  https://doi.org/10.2807/1560-7917.ES.2025.30.45.2500285  PMID: 41234195 
  14. Di Pilato V, Codda G, Ball L, Giacobbe DR, Willison E, Mikulska M, et al. Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic. J Fungi (Basel). 2021;7(2):140.  https://doi.org/10.3390/jof7020140  PMID: 33672021 
  15. Sticchi C, Raso R, Ferrara L, Vecchi E, Ferrero L, Filippi D, et al. Increasing Number of Cases Due to Candida auris in North Italy, July 2019-December 2022. J Clin Med. 2023;12(5):1912.  https://doi.org/10.3390/jcm12051912  PMID: 36902700 
  16. Amadesi S, Palombo M, Bovo F, Liberatore A, Vecchi E, Cricca M, et al. Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021. Microb Drug Resist. 2024;30(1):50-4.  https://doi.org/10.1089/mdr.2023.0150  PMID: 37851491 
  17. Di Lorenzo A, Triggiano F, Lopuzzo M, Piccolomo L, Triggiani M, Grasso S, et al. Candida auris cluster in a large third level Italian hospital: a case series. IJID Reg. 2024;13:100468.  https://doi.org/10.1016/j.ijregi.2024.100468  PMID: 39507392 
  18. Rimoldi SG, Nodari R, Rizzo A, Tamoni A, Longobardi C, Pagani C, et al. First imported case of Candida auris infection in Milan, Italy: genomic characterisation. Infection. 2024;52(4):1633-8.  https://doi.org/10.1007/s15010-024-02232-x  PMID: 38557967 
  19. Fioriti S, Pallotta F, D’Achille G, Cirioni O, Simonetti O, Neubauer D, et al. In vitro activities of lipopeptides against fluconazole-resistant Candida auris. Microbiol Spectr. 2025;13(4):e0178624.  https://doi.org/10.1128/spectrum.01786-24  PMID: 40013777 
  20. European Centre for Disease Prevention and Control (ECDC). Candida auris outbreak in healthcare facilities in northern Italy, 2019-2021. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-candida-auris-Feb2022.pdf
  21. De Carolis E, Marchionni F, La Rosa M, Meis JF, Chowdhary A, Posteraro B, et al. Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer. Front Cell Infect Microbiol. 2021;11:645049.  https://doi.org/10.3389/fcimb.2021.645049  PMID: 33796487 
  22. Giovagnorio F, Geremia N, Scarparo C, Panese S, Bradariolo S, Berti C, et al. Successful control measures to treat the transmission of Candida auris in Northern Italian Hospital. New Microbiol. 2024;46(4):395-9. PMID: 38252051 
  23. Alderotti G, Arzilli G, Azzari C, Baggiani A, Barnini S, Bartoloni A, et al. La sorveglianza epidemiologica delle malattie infettive in Toscana 2022. [Epidemiological surveillance of infectious diseases in Tuscany 2022]. Florence: Tuscany Regional Department of Health (ARS); 2023. (ARS reports series, n. 5, 26). Italian.
  24. Arzilli G, Baggiani A, Baglivo F, Barnini S, Bartolacci S, De Angelis L, et al. L’antibiotico-resistenza e l’uso di antibiotici in Toscana nel 2024. [Antibiotic resistance and the use of antibiotics in Tuscany in 2024]. In: Forni S, Gemmi F, editors. Florence: Tuscany Regional Department of Health (ARS); 2025. (ARS document series, 126). ISSN 1970-3244. Italian.
  25. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589-95.  https://doi.org/10.1093/bioinformatics/btp698  PMID: 20080505 
  26. Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, et al. Versatile and open software for comparing large genomes. Genome Biol. 2004;5(2):R12.  https://doi.org/10.1186/gb-2004-5-2-r12  PMID: 14759262 
  27. Garrison EG, Marth G. Haplotype-based variant detection from short-read sequencing. ArXiv Prepr 2012:q-bio.GN/1207.3907.
  28. Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32(1):268-74.  https://doi.org/10.1093/molbev/msu300  PMID: 25371430 
  29. Welsh RM, Misas E, Forsberg K, Lyman M, Chow NA. Candida auris whole-genome sequence benchmark dataset for phylogenomic pipelines. J Fungi (Basel). 2021;7(3):214.  https://doi.org/10.3390/jof7030214  PMID: 33809682 
  30. Muñoz JF, Welsh RM, Shea T, Batra D, Gade L, Howard D, et al. Clade-specific chromosomal rearrangements and loss of subtelomeric adhesins in Candida auris. Genetics. 2021;218(1):iyab029.  https://doi.org/10.1093/genetics/iyab029  PMID: 33769478 
  31. Suphavilai C, Ko KKK, Lim KM, Tan MG, Boonsimma P, Chu JJK, et al. Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe. 2024;5(9):100878.  https://doi.org/10.1016/S2666-5247(24)00101-0  PMID: 39008997 
  32. Surleac M, Stanciu AM, Florea D, Paraschiv S, Tălăpan D, Flonta M, et al. A clinical and molecular analysis of Candidozyma auris strains from Romania, 2022-2023. Microbiol Spectr. 2025;13(7):e0280924.  https://doi.org/10.1128/spectrum.02809-24  PMID: 40387391 
  33. Clausen PTLC, Aarestrup FM, Lund O. Rapid and precise alignment of raw reads against redundant databases with KMA. BMC Bioinformatics. 2018;19(1):307.  https://doi.org/10.1186/s12859-018-2336-6  PMID: 30157759 
  34. Katsiari M, Nikolaou C, Palla E, Theodoridou K, Tsakris A, Vrioni G. Impact of Candida auris on Critically Ill Patients: A Three-Year Observational Study in a Greek Intensive Care Unit. Pathogens. 2025;14(4):328.  https://doi.org/10.3390/pathogens14040328  PMID: 40333088 
  35. Lyman M, Forsberg K, Sexton DJ, Chow NA, Lockhart SR, Jackson BR, et al. Worsening Spread of Candida auris in the United States, 2019 to 2021. Ann Intern Med. 2023;176(4):489-95.  https://doi.org/10.7326/M22-3469  PMID: 36940442 
  36. United States Centers for Disease Control and Prevention (CDC). Screening Recommendations for Healthcare Facilities 2024. Atlanta: CDC. Available from: https://www.cdc.gov/candida-auris/hcp/screening-hcp/index.html
  37. Kim HY, Nguyen TA, Kidd S, Chambers J, Alastruey-Izquierdo A, Shin J-H, et al. Candida auris-a systematic review to inform the world health organization fungal priority pathogens list. Med Mycol. 2024;62(6):myae042.  https://doi.org/10.1093/mmy/myae042  PMID: 38935900 
/content/10.2807/1560-7917.ES.2026.31.18.2500730
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error